Strength
200 mg/1
Manufacturer
Novadoz Pharmaceuticals LLCNDC
72205005108
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
ALBENDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA213435On Market Since
2/24/2021
Pharmacological Classes
Anthelmintic
Cytochrome P450 1A Inducers